These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 23612727)
1. Primary resistance phenomena to oncolytic measles vaccine viruses. Noll M; Berchtold S; Lampe J; Malek NP; Bitzer M; Lauer UM Int J Oncol; 2013 Jul; 43(1):103-12. PubMed ID: 23612727 [TBL] [Abstract][Full Text] [Related]
2. An armed oncolytic measles vaccine virus eliminates human hepatoma cells independently of apoptosis. Lampe J; Bossow S; Weiland T; Smirnow I; Lehmann R; Neubert W; Bitzer M; Lauer UM Gene Ther; 2013 Nov; 20(11):1033-41. PubMed ID: 23719065 [TBL] [Abstract][Full Text] [Related]
3. Enhanced killing of ovarian carcinoma using oncolytic measles vaccine virus armed with a yeast cytosine deaminase and uracil phosphoribosyltransferase. Hartkopf AD; Bossow S; Lampe J; Zimmermann M; Taran FA; Wallwiener D; Fehm T; Bitzer M; Lauer UM Gynecol Oncol; 2013 Aug; 130(2):362-8. PubMed ID: 23676551 [TBL] [Abstract][Full Text] [Related]
4. A novel armed oncolytic measles vaccine virus for the treatment of cholangiocarcinoma. Lange S; Lampe J; Bossow S; Zimmermann M; Neubert W; Bitzer M; Lauer UM Hum Gene Ther; 2013 May; 24(5):554-64. PubMed ID: 23550539 [TBL] [Abstract][Full Text] [Related]
5. Pulsed versus continuous application of the prodrug 5-fluorocytosine to enhance the oncolytic effectiveness of a measles vaccine virus armed with a suicide gene. Yurttas C; Berchtold S; Malek NP; Bitzer M; Lauer UM Hum Gene Ther Clin Dev; 2014 Jun; 25(2):85-96. PubMed ID: 24933569 [TBL] [Abstract][Full Text] [Related]
9. Human precision-cut liver tumor slices as a tumor patient-individual predictive test system for oncolytic measles vaccine viruses. Zimmermann M; Armeanu S; Smirnow I; Kupka S; Wagner S; Wehrmann M; Rots MG; Groothuis GM; Weiss TS; Königsrainer A; Gregor M; Bitzer M; Lauer UM Int J Oncol; 2009 May; 34(5):1247-56. PubMed ID: 19360338 [TBL] [Abstract][Full Text] [Related]
17. Enhanced cytotoxicity with a novel system combining the paclitaxel-2'-ethylcarbonate prodrug and an HSV amplicon with an attenuated replication-competent virus, HF10 as a helper virus. Ishida D; Nawa A; Tanino T; Goshima F; Luo CH; Iwaki M; Kajiyama H; Shibata K; Yamamoto E; Ino K; Tsurumi T; Nishiyama Y; Kikkawa F Cancer Lett; 2010 Feb; 288(1):17-27. PubMed ID: 19604626 [TBL] [Abstract][Full Text] [Related]
18. Experimental therapy of allogeneic solid tumors induced in athymic mice with suicide gene-transducing replication-competent foamy virus vectors. Heinkelein M; Hoffmann U; Lücke M; Imrich H; Müller JG; Meixensberger J; Westphahl M; Kretschmer A; Rethwilm A Cancer Gene Ther; 2005 Dec; 12(12):947-53. PubMed ID: 15905857 [TBL] [Abstract][Full Text] [Related]
19. Measles virus as an oncolytic vector platform. Blechacz B; Russell SJ Curr Gene Ther; 2008 Jun; 8(3):162-75. PubMed ID: 18537591 [TBL] [Abstract][Full Text] [Related]